Xyla Oncology Insourcing
Keep momentum on this opportunity
Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.
- Save and reuse search filters
- Track opportunities as pursuits
- Get notified when new notices match
Keep this notice in a shortlist so you can return to it without starting a bid.
Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.
Key information
Overview
Insourcing of consultants to provide oncology activity.
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>Key Criteria:<br/>1. Ability to provide the required service.<br/><br/>2.Consideration of service fees and timescales for provision.<br/><br/>3. Cost effective.<br/><br/>Decision maker: Pat Rubin, Divisional General Manager, approved by Trust Management Group.
Provision of insourcing within Oncology.<br/><br/>This is confirmation of an award having been made based on a framework agreement and without competition.<br/><br/>The contract will run from 26/10/2026 to 25/01/2027, with a value of £225,000.
Public Contracts Regulations 2015 (Directive 2014/24/EU)
Award procedure without prior publication of a call for competition This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Lot 1: Bids: 1 Lot 1: Lowest valid bid value: 225000 GBP Lot 1: Highest valid bid value: 225000 GBP